24.07.20151561
The FDA and Sanofi/Regeneron announced that the agency has approved alirocumab, a PCSK9 inhibitor, for lowering of LDL in addition to diet and maximally tolerated statin therapy in patients with heterozygous familial hypercholesterolemia or those with clinical atherosclerotic CVD.
23.07.20151412
Dislipidemia in type 2 diabetes mellitus contributes to arterial endothelial dysfunction and an increased risk of cardiovascular disease.
22.07.20151588
The drug, to be marketed as Repatha (Amgen), is the first PCSK9 inhibitor to be approved for intensive reduction of LDL, according to a company press release.
21.07.20151557
Patients with psoriasis, and particularly those with psoriatic arthritis, were at increased risk of developing arrhythmia, independent of traditional cardiovascular risk factors, according to recently published study results.
21.07.20151529
To participate in the expertise scientist has to be registered in the Science Index as author of scientific articles, an academic degree and total number of citations for 5 years (2009-2013) not less than fixed (different for each research field).
20.07.20151900
Stroke frequently complicates infective endocarditis (IE). However, the temporal relationship between these diseases is uncertain.
17.07.20151954
Patients undergoing primary PCI are three times more likely to experience ischemic stroke than hemorrhagic stroke, according to recent findings.